Page last updated: 2024-10-22
albuterol and Pus
albuterol has been researched along with Pus in 1 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Research Excerpts
| Excerpt | Relevance | Reference |
|---|
| "Oral albuterol may be more effective than commonly used antibiotics in relieving the symptoms of acute bronchitis." | 9.07 | A comparison of albuterol and erythromycin for the treatment of acute bronchitis. ( Hueston, WJ, 1991) |
| "Oral albuterol may be more effective than commonly used antibiotics in relieving the symptoms of acute bronchitis." | 5.07 | A comparison of albuterol and erythromycin for the treatment of acute bronchitis. ( Hueston, WJ, 1991) |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Hueston, WJ | 1 |
Clinical Trials (1)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status |
|---|
| Effect of Oral Procaterol on Chronic Persistent Cough Following Upper Respiratory Tract Infection: Double-Blind Randomized Placebo-Controlled Trial[NCT02349919] | | 74 participants (Anticipated) | Interventional | 2015-03-31 | Recruiting |
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Trials
1 trial available for albuterol and Pus